African-Americans are more likely to be diagnosed with schizophrenia than persons of other ethnic identities, necessitating an understanding of this group’s perceptions of the mental health system. Interviews with 10 African-American caregivers of persons with schizophrenia underwent qualitative data analysis to elucidate perspectives on medication adherence and their caretaking roles and supports. Medication adherence-related themes (interactive strategies, organizational strategies) and non-medication-related themes (support of patient, support of caregiver) were detected. These results describe the complex role that African-American caregivers of persons with schizophrenia undertake and identify possible interventions to address related mental health disparities.
AdebimpeVR (1981) Overview: White norms and psychiatric diagnosis of black patients. American Journal of Psychiatry138: 279–285.
2.
American Psychiatric Association (2013) Diagnostic and Statistical Manual-5, Washington, DC: American Psychiatric Association.
3.
AtdjianSVegaWA (2005) Disparities in mental health treatment in US racial and ethnic minority groups: Implications for psychiatrists. Psychiatric Services56: 1600–1602.
4.
BalsaAIMcGuireTG (2001) Statistical discrimination in health care. Journal of Health Economics20: 881–907.
5.
BlackwellB (1996) From compliance to alliance: A quarter century of research. The Netherlands Journal of Medicine48: 140–149.
6.
Braun V and Clarke V (2006) Using thematic analysis in psychology. Qualitative Research in Psychology 3: 77–101.
7.
BresnahanMBeggMDBrownAet al. (2007) Race and risk of schizophrenia in a US birth cohort: Another example of health disparity?International Journal of Epidemiology36: 751–758.
8.
BuckalewLWSallisRE (1986) Patient compliance and medication perception. Journal of Clinical Psychology42: 49–53.
9.
Cloutier M, Aigbogun MS, Guerin A, et al. (2016) The economic burden of schizophrenia in the United States in 2013. The Journal of Clinical Psychiatry 77: 764–771.
10.
Coffman JM, Rosenoff E and Grumbach K (2001) Racial/ethnic disparities in nursing. Health Affairs 20: 263–272.
11.
Cohen JJ, Gabriel BA and Terrell C (2002) The case for diversity in the health care workforce. Health Affairs 21: 90–102.
12.
CramerJARosenheckR (1998) Compliance with medication regimens for mental and physical disorders. Psychiatric Services49: 196–201.
13.
CramerJARosenheckR (1999) Enhancing medication compliance for people with serious mental illness. Journal of Nervous & Mental Disease187: 53–55.
14.
DiMatteoMR (2004) Social support and patient adherence to medical treatment: A meta-analysis. Health Psychology23: 207–218.
15.
DixonLBLehmanAF (1995) Family interventions for schizophrenia. Schizophrenia Bulletin21: 631–643.
16.
EaddyMGroggALocklearJ (2005) Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clinical Therapeutics27: 263–272.
17.
FalloonIRBoydJLMcGillCWet al. (1982) Family management in the prevention of exacerbations of schizophrenia: A controlled study. New England Journal of Medicine306: 1437–1440.
18.
FentonWSBlylerCRHeinssenRK (1997) Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin23: 637–651.
19.
FinleyLY (1998) The cultural context: Families with severe mental illness. Psychiatric Rehabilitation Journal21: 230–240.
20.
FransonKLSmithSL (1998) Psychotherapeutic agents in older adults. Compliance: Problems and opportunities. Clinics in Geriatric Medicine14: 7–16.
21.
GilmerTPDolderCRLacroJPet al. (2004) Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry161: 692–699.
22.
HastingsJFJonesLVMartinPP (2015) African Americans and Depression: Signs, Awareness, Treatments, and Interventions, Lanham: Rowman & Littlefield Publishers.
23.
JungbauerJStellingKDietrichSet al. (2004) Schizophrenia: Problems of separation in families. Journal of Advanced Nursing47: 605–613.
24.
KreyenbuhlJBuchananRWDickersonFBet al. (2010) The schizophrenia patient outcomes research team (PORT): Updated treatment recommendations 2009. Schizophrenia Bulletin36: 94–103.
25.
LawsonWB (1996) Clinical issues in the pharmacotherapy of African-Americans. Psychopharmacology Bulletin32: 275–281.
26.
LeeY-RSungK-T (1998) Cultural influences on caregiving burden: Cases of Koreans and Americans. The International Journal of Aging and Human Development46: 125–141.
27.
LehmanAFSteinwachsDM (1998) Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin24: 1–10.
28.
MarderSR (1998) Facilitating compliance with antipsychotic medication. Journal of Clinical Psychiatry59(Suppl 3): 21–25.
29.
McDonellMGShortRABerryCMet al. (2003) Burden in schizophrenia caregivers: Impact of family psychoeducation and awareness of patient suicidality. Family Process42: 91–103.
30.
MilesMBHubermanAMSaldanaJ (2013) Qualitative Data Analysis: A Methods Sourcebook, Thousand Oaks, CA: SAGE Publications, Incorporated.
31.
MinskySVegaWMiskimenTet al. (2003) Diagnostic patterns in Latino, African American, and European American psychiatric patients. Archives of General Psychiatry60: 637–644.
32.
Nadeem E, Lange JM, Edge D, et al. (2007) Does stigma keep poor young immigrant and US-born black and Latina women from seeking mental health care? Psychiatric Services.
33.
OpolkaJLRascatiKLBrownCMet al. (2003) Role of ethnicity in predicting antipsychotic medication adherence. Annals of Pharmacotherapy37: 625–630.
34.
PiatMRicardNSabettiJet al. (2007) The values and qualities of being a good helper: A qualitative study of adult foster home caregivers for persons with serious mental illness. International Journal of Nursing Studies44: 1418–1429.
35.
PinquartMSörensenS (2005) Ethnic differences in stressors, resources, and psychological outcomes of family caregiving: A meta-analysis. The Gerontologist45: 90–106.
36.
Ramirez GarciaJIChangCLYoungJSet al. (2006) Family support predicts psychiatric medication usage among Mexican American individuals with schizophrenia. Social Psychiatry & Psychiatric Epidemiology41: 624–631.
37.
RüschNAngermeyerMCCorriganPW (2005) Mental illness stigma: Concepts, consequences, and initiatives to reduce stigma. European Psychiatry20: 529–539.
38.
SalesE (2003) Family burden and quality of life. Quality of Life Research12: 33–41.
39.
SartoriusNSchulzeH (2005) Reducing the Stigma of Mental Illness: A Report From a Global Association, Cambridge, UK: Cambridge University Press.
40.
SatcherD (2000) Mental health: A report of the surgeon general – Executive summary. Professional Psychology: Research and Practice31: 5–13.
41.
SchulzRSherwoodPR (2008) Physical and mental health effects of family caregiving. Journal of Social Work Education44: 105–113.
42.
SegalSPBolaJRWatsonMA (1996) Race, quality of care and antipsychotic prescribing practices in psychiatric emergency rooms. Psychiatric Services47: 282–286.
43.
SerbanGThomasA (1974) Attitudes and behaviors of acute and chronic schizophrenic patients regarding ambultory treatment. American Journal of Psychiatry131: 991–995.
44.
SimonRJFleissJLGurlandBJet al. (1973) Depression and schizophrenia in hospitalized black and white mental patients. Archives of General Psychiatry28: 509.
45.
Staller KM (2015) Qualitative analysis: The art of building bridging relationships. Qualitative Social Work 14: 145–153.
46.
StrakowskiSMFlaumMAmadorXet al. (1996) Racial differences in the diagnosis of psychosis. Schizophrenia Research21: 117–124.
47.
TorreyEF (2001) Surviving Schizophrenia: A Manual for Families, Consumers, and Providers, New York: Harper Perennial.
48.
TrierweilerSJNeighborsHWMundayCet al. (2000) Clinician attributions associated with the diagnosis of schizophrenia in African American and non-African American patients. Journal of Consulting and Clinical Psychology68: 171.
49.
ValensteinMBlowFCCopelandLAet al. (2004) Poor antipsychotic adherence among patients with schizophrenia: Medication and patient factors. Schizophrenia Bulletin30: 255–264.
50.
WeidenPRapkinBMottTet al. (1994) Rating of medication influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin20: 297–310.
51.
WhaleyALHallBN (2009) Cultural themes in the psychotic symptoms of African American psychiatric patients. Professional Psychology: Research and Practice40: 75.
52.
WuEQBirnbaumHGShiLet al. (2005) The economic burden of schizophrenia in the United States in 2002. Journal of Clinical Psychiatry66: 1122–1129.
53.
WyattRJ (1991) Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin17: 325–351.
